Vincenzo Emanuele Chiuri
- Clinical and therapeutic perspectives of gene expression profiling for breast cancerV E Chiuri
Oncologia Medica, Ospedale V Fazzi, Lecce
Ann Oncol 18:vi58-62. 2007..These predictors, however, need to be validated by prospective clinical trials...
- Efficacy and safety of the combination of docetaxel (Taxotere) with targeted therapies in the treatment of solid malignanciesVincenzo Emanuele Chiuri
Oncologia Medica, Ospedale V Fazzi, Pizza F Muratore, 73100 Lecce, Italy
Curr Drug Targets 10:982-1000. 2009..Herein we reported the efficacy and safety results of the most significant clinical trials evaluating different combinations and schedules of docetaxel plus biological therapeutics...
- Which patients with estrogen receptor-positive early breast cancer should be treated with adjuvant chemotherapy?Vincenzo Emanuele Chiuri
Oncologia Medica, Ospedale V Fazzi, Lecce, Italy
Oncology 77:18-22. 2009....
- Which role for EGFR therapy in breast cancer?Vito Lorusso
Medical Oncology Unit, Hospital Vito Fazzi, Lecce, Italy
Front Biosci (Schol Ed) 4:31-42. 2012..This paper focuses on the therapeutic strategy for treatment of HER2 overexpressing breast cancer in advanced stages of disease, as well as in the adjuvant and neo-adjuvant settings...
- Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisalAndrea Tinelli
Department of Gynaecology and Obstetrics, Vito Fazzi Hospital, Lecce, Italy
Cancer Metastasis Rev 29:339-50. 2010..Prophylactic surgery has been shown to effectively decrease cancer risk, and it has the possibility to substantially reduce ovarian cancer mortality...